All News
Advertisement
Advertisement
Pharmaceutical Executive
Grant-boosted Euripid pushes revitalized defense of external reference pricing system.
Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive May 2017 issue in an interactive PDF format.
Advertisement
Pharmaceutical Executive
Jill Wechsler outlines how the new FDA commissioner tasked with curbing regulation, speeding approvals-and collecting more fees to do it.
Pharmaceutical Executive
Click the title above to open the Pharmaceutical Executive April 2017 issue in an interactive PDF format.
March 28, 2017
March 20, 2017
March 15, 2017
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
3
Developing Better Drugs, Not Just More Drugs: Q&A with David Hung
4
Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising, Alleging Misleading Dosing Comparisons
5